SUMMIT, N.J., Sept. 21, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced the publication of new real-world evidence (RWE) that demonstrated an MF59® adjuvanted, ...
This is a preview. Log in through your library . Abstract Purpose The aim of this study is to investigate the role of health-related quality-of-life (QoL) data in relative effectiveness assessments ...
Quadrivalent recombinant influenza vaccines contain three times the amount of hemagglutinin protein as standard-dose egg-based vaccines, and the recombinant formulation is not susceptible to antigenic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A recombinant flu vaccine had a relative effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results